T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amazon
AMZN
$2.44T
| $13.6B | 2.9% |
457,828,700
+42,523,200
| +10% | +$1.21B |
|
2
Microsoft
MSFT
$2.9T
| $9.23B | 1.97% |
167,152,429
-3,704,755
| -2% | -$194M |
|
3
Meta Platforms (Facebook)
META
$1.49T
| $7.75B | 1.65% |
67,941,105
+7,102,164
| +12% | +$749M |
|
4
Booking.com
BKNG
$156B
| $7.63B | 1.63% |
147,974,425
+12,022,975
| +9% | +$576M |
|
5
Alphabet (Google) Class C
GOOG
$4.11T
| $7.17B | 1.53% |
192,416,760
-5,520,100
| -3% | -$198M |
|
6
Danaher
DHR
$138B
| $6.98B | 1.49% |
109,467,044
-8,667,242
| -7% | -$517M |
|
|
7
Alphabet (Google) Class A
GOOGL
$4.12T
| $6.16B | 1.32% |
161,532,820
-2,674,520
| -2% | -$98.5M |
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $5.65B | 1.21% |
21,066,658
-627,360
| -3% | -$180M |
|
9
Visa
V
$677B
| $5.64B | 1.2% |
73,786,315
-6,246,156
| -8% | -$454M |
|
10
Apple
AAPL
$4.97T
| $5.59B | 1.19% |
205,051,412
+3,824,996
| +2% | +$95.3M |
|
11
Boeing
BA
$169B
| $4.72B | 1.01% |
37,199,873
-3,859,412
| -9% | -$479M |
|
12
UnitedHealth
UNH
$382B
| $4.71B | 1.01% |
36,549,528
-1,126,849
| -3% | -$133M |
|
13
Bristol-Myers Squibb
BMY
$129B
| $4.17B | 0.89% |
65,254,410
+16,444,038
| +34% | +$1.04B |
|
14
GE Aerospace
GE
$364B
| $4.12B | 0.88% |
27,041,437
-1,517,383
| -5% | -$214M |
|
|
MRSH
15
Marsh
MRSH
$94.3B
| $4.05B | 0.87% |
66,659,213
+101,281
| +0.2% | +$5.67M |
|
16
Pfizer
PFE
$143B
| $4.04B | 0.86% |
143,631,073
+25,117,398
| +21% | +$717M |
|
|
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
| $3.93B | 0.84% |
28,214,386
-81,041
| -0.3% | -$11.9M |
|
18
American Airlines Group
AAL
$9.82B
| $3.87B | 0.83% |
94,290,310
+11,933,373
| +14% | +$480M |
|
|
19
Philip Morris
PM
$309B
| $3.8B | 0.81% |
38,758,659
+14,147,729
| +57% | +$1.3B |
|
20
Mastercard
MA
$498B
| $3.73B | 0.8% |
39,454,379
-1,202,141
| -3% | -$106M |
|
21
Morgan Stanley
MS
$319B
| $3.56B | 0.76% |
142,188,722
+12,270,800
| +9% | +$313M |
|
22
Elevance Health
ELV
$81.5B
| $3.42B | 0.73% |
24,607,547
-1,233,148
| -5% | -$165M |
|
23
Intuitive Surgical
ISRG
$127B
| $3.36B | 0.72% |
50,374,773
-6,894,018
| -12% | -$427M |
|
24
Thermo Fisher Scientific
TMO
$214B
| $3.34B | 0.71% |
23,583,828
-1,510,915
| -6% | -$202M |
|
25
Lowe's Companies
LOW
$121B
| $3.31B | 0.71% |
43,737,067
-2,890,085
| -6% | -$204M |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.